<DOC>
	<DOCNO>NCT01860716</DOCNO>
	<brief_summary>Impact melatonin organ donor pretreatment liver transplant recipient : prospective , randomize , double-blind trial . OBJECTIVES . To establish efficacy melatonin administer encephalic death donor ( EDD ) liver transplantation . The aim improve functional quality retrieve organ , attenuate lesion ischemia-reperfusion mediator , provide graft great resistance post-transplant aggression . METHODOLOGY . Prospective , randomize , double-blind , pilot trial evaluate precondition melatonin versus placebo EDDs . Two group , melatonin control-placebo , n=30 per group . Administration donor via NG tube 30mg melatonin placebo ( lactose ) upon inclusion trial , 60 minute prior commencement surgery follow laparotomy extraction . Evaluation response treatment : A ) Conventional clinical , hemodynamic , analytical histopathological parameter donor recipient . B ) Plasma determination : oxidative/nitrosative stress ; acute phase protein ; cellular humoral immunity ; NT-proBNP cystatin C ; endocrine profile ; melatonin level . C ) Determinations liver tissue : quantification malonyldialdehyde-4hydroxyalkenals protein carbonyl content ; cellular mitochondrial membrane fluidity ; marker tissue-vascular damage proliferation : transforming growth factor-beta ( TGF-β ) ; hypoxia-inducible factor ( HIF ) vascular endothelial growth factor ( VEGF ) . Data analyze follow prospectively define plan intention-to-treat analysis .</brief_summary>
	<brief_title>Impact Melatonin Pretreatment Organ Donor Influence Evolution Liver Transplant .</brief_title>
	<detailed_description>This study do Hospital Clinico Lozano Blesa ( Zaragoza , Spain ) , promote Health Science Aragon Institute principal investigator F. Agustín García Gil ( Surgical Service ) . It start April-May 2013 finish 12 month later approximately . The study sponsor I+CS ( Aragon Institute Health Sciences ) .</detailed_description>
	<mesh_term>Melatonin</mesh_term>
	<criteria>A ) Donors 1 . Encephalicdeath ( ED ) organ donor situated ICUs accredit hospital Zaragoza meet every one follow criterion . 2 . Being 16 year old old . 3 . Informed consent donation sign immediate family . 4 . Informed consent inclusion donor study . 5 . Receive intensive treatment standard maintenance donor ED , accordance universally accept protocol Organizacion Nacional de Trasplantes ( ONT ) , Aragon Autonomous Transplant Coordination , ICUs participate hospital study . B ) Liver transplant recipient 1 . Being 18 year old old less 68 year age . 2 . Informed consent procedure LT sign . 3 . Informed consent patient inclusion study , sign day consent LT. A ) Donors A potential encephalicdeath organ donor include study either follow criterion : 1 . Absence either sign informed consent : organ donation inclusion study . 2 . No standard concomitant treatment management donor ED . B ) Liver transplant recipient 1 . Absence either sign informed consent : liver transplantation inclusion study . 2 . Split , domino multiorgan transplantation . 3 . Grafts remove surgical team . 4 . Pregnant woman fertile use contraceptive measure highly effective .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Melatonin , liver transplant , oxidative stress</keyword>
</DOC>